C. Diff
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Open-Label Extension of CP101 Trials Evaluating Oral Full-Spectrum Microbiota™ (CP101) in Subjects With Recurrence of Clostridium Difficile Infection (NCT03497806) | Finch Research and Development LLC. | 2018-05-01 |
Track C. Diff automatically
Every clearance here is in the API, with alerts when new ones post.